Teva says vaccine makers have not taken its offer to help produce jabs | Financial Times
Teva Pharmaceutical Industries (NYSE:TEVA) - Stock Price, News & Analysis - Simply Wall St
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Teva Reports Earnings Tomorrow. Here's What to Expect. | Barron's
Efi Benmeir - SVP Finance & CFO International Markets - Teva Pharmaceutical Industries Ltd. | LinkedIn
Teva looks for $20B-plus from bond sale to finance Allergan deal | Fierce Pharma
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Proposes $5B Settlement for Thousands of Opioid Lawsuits | BioSpace
Teva Announces Appointment of New Chief Financial Officer | Business Wire
Highest paying jobs at Teva Pharmaceuticals
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva Pharmaceutical Industries Stock Is Estimated To Be Fairly Valued
Teva Reports Fourth Quarter and Full Year 2020 Financial Results | Business Wire
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Teva exits Massachusetts as Cambridge site falls victim to restructuring - Boston Business Journal
Teva Pharmaceutical (TEVA) presents at Global High Yiled & Leveraged Finance Virtual Conference-slideshow (NYSE:TEVA) | Seeking Alpha
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
/cloudfront-us-east-2.images.arcpublishing.com/reuters/CCBS56SBRRKUDM7JEVVE3UOQEE.jpg "Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters")
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva to pay $85m to Oklahoma over opioid case | Financial Times
Amit Hazan - Head of Corporate Finance & Banking Relations - Teva Pharmaceuticals | LinkedIn
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Zach (Tzahi) Davidi - Sr. Finance director - Teva Pharmaceuticals | LinkedIn
Yahoo Finance on Twitter: "$TEVA Pharmaceutical is set to pay $4.25 billion in settlements in opioid cases, $CS names new CEO, $DB warns of challenging second half for 2022, and $TWTR is
